Moshkevich Solomon, an officer at Natera, Inc., has sold shares of the company in a series of transactions reported on October 2, 2026. This activity is significant as it highlights the ongoing trading dynamics within the medical diagnostics industry.
Natera, Inc. operates in the medical laboratories sector, specifically focusing on clinical diagnostics. The company is incorporated in Delaware and has been actively filing with the SEC. Its recent filings include various forms, with the latest being a Form 4, which reports changes in ownership.
According to the filing, Solomon sold a total of 3,000 shares on October 1, 2026, at prices ranging from approximately $411.55 to $415.19 per share. The filing states, "The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024." Following these transactions, Solomon retains ownership of 106,914 shares.
This series of transactions may affect stakeholders, including investors and analysts monitoring Natera's stock performance and executive actions. The medical laboratories sector continues to experience fluctuations, and insider trading activities can provide insights into company strategies and market conditions.
The filing does not say what happens next.
Details of the Transactions
In the reported transactions, Moshkevich Solomon sold shares of Natera, Inc. in three separate transactions on October 1, 2026. The first transaction involved the sale of 200 shares at a price of $411.62 per share. The second transaction included the sale of 954 shares at a price of $413.1066 per share. Lastly, Solomon sold 1,846 shares at a price of $415.0691 per share. Each of these transactions was executed under the aforementioned Rule 10b5-1 trading plan.
Ownership Status
Following these transactions, Solomon's ownership decreased to 106,914 shares of Natera, Inc. The filing indicates that all shares sold were common stock, and Solomon retains direct ownership of the remaining shares.
"The reported prices in the filing are weighted average prices, and the transactions occurred at varying prices within specified ranges for each sale."
The filing does not provide additional context regarding the strategic reasons behind the share sales or any potential future plans for further transactions by Solomon.